On Mar. 26, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), addressed Heads of…
On Mar. 26, 2020, the FDA reported that it had become increasingly clear that the FDA needed to…
On Mar. 26, 2020, in a forecast based on recent data analyses, Institute for Health Metrics (IHME) researchers…
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
On Mar. 26, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
On Mar. 26, 2020, Dynavax and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a collaboration supporting the…
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
On Mar. 26, 2020, Henry Schein announced the availability of an antibody rapid blood test, known as Standard…
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
On Mar. 26, 2020, iBio announced that it had entered into a development agreement with AzarGen Biotechnologies. Signed…
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
On Mar. 25, 2020, Philips announced that it was increasing the production of certain critical care products and…
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
On Mar. 25, 2020, Mylan announced that it had waived its exclusive rights in the U.S. to distribute…
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…